ecopipam has been researched along with am 251 in 1 studies
Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) | Studies (am 251) | Trials (am 251) | Recent Studies (post-2010) (am 251) |
---|---|---|---|---|---|
147 | 18 | 34 | 948 | 1 | 507 |
Protein | Taxonomy | ecopipam (IC50) | am 251 (IC50) |
---|---|---|---|
Cannabinoid receptor 1 | Homo sapiens (human) | 0.0892 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Makriyannis, A; Olszewska, T; Salamone, JD; Sink, KS; Vemuri, VK | 1 |
1 other study(ies) available for ecopipam and am 251
Article | Year |
---|---|
Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior.
Topics: Animals; Benzazepines; Choice Behavior; Conditioning, Operant; Dopamine Antagonists; Feeding Behavior; Food Preferences; Injections, Intraperitoneal; Male; Motivation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Salicylamides | 2008 |